Previous applications of TUS were limited, as they were imprecise and too weak to target areas deeper in the brain. Parkinson ...

A hallmark of Parkinson’s is the presence of abnormal protein clumps, known as Lewy bodies, in the brain. However, some ...

"Furthermore, patients with RLS who were not treated with dopamine agonists tended to be at increased risk of developing ...

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...

B55alpha, that controls both the cleanup of damaged mitochondria and the creation of new ones. In Parkinson’s disease models, ...

Researchers have designed a peptide that prevents the deadly misfolding of alpha-synuclein, the protein behind Parkinson’s ...

An acclaimed researcher is an expert at explaining complicated problems. Now she has to confront the most vexing question: ...

Researchers have designed a peptide that stabilizes a key brain protein linked to Parkinson’s. Scientists from the University of Bath, working with colleagues at the Universities of Oxford and Bristol ...

Drugs commonly prescribed to treat Parkinson's disease have been linked to impulse control disorders such as pathological gambling, compulsive buying, hypersexuality and binge eating in some patients, ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care ...

Scientists discover that gut bacteria and B vitamins may influence Parkinson's disease, offering a potentially safe ...